Respiratorius AB (publ)
Developing novel drugs to treat aggressive lymphoma cancers.
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 1998
- Grunnlagt
Nøkkelbeslutningstakere
Johan Drott
CEO
Karin Wehlin
Chairman of the Board
Kristina Drott
Board member
Mia Lundblad
Board member
Beskrivelse
Respiratorius AB (publ) is a specialized biotechnology company focused on developing novel drug candidates for treating aggressive cancers. Their primary mission is to reduce the global burden of aggressive lymphoma, particularly Diffuse large B-cell lymphoma (DLBCL). The company bases its drug cand...